Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Adjuvanted VZV subunit vaccine gE/AS01B is more immunogenic than Varilrix

Nov. 4, 2010

Panobinostat has antitumor activity in phase II trial in SCLC

Nov. 4, 2010

AMG-386 is active in renal cell carcinoma and ovarian cancer

Nov. 4, 2010

ENB-0040 shows promise to treat hypophosphatasia in children

Nov. 4, 2010

Clinical data reported on cilengitide in NSCLC and glioblastoma

Nov. 3, 2010

Afatinib is active in patients with head and neck and lung cancers

Nov. 3, 2010

Manageable toxicity seen with brivanib alaninate plus cetuximab and irinotecan in colorectal cancer

Nov. 3, 2010

Antibodies targeting LINGO-1 promote myelination in preclinical studies

Nov. 3, 2010

Azathioprine and prednisolone reduce relapse rates in neuromyelitis optica

Nov. 3, 2010

Mild toxicity and disease stabilizations seen with L19TNF-alpha in patients with cancer

Nov. 2, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...